| 000 | 01040 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515063041.0 | ||
| 264 | 0 | _c20070406 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.297.13.1429-a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGeller, Jordan L | |
| 245 | 0 | 0 |
_aProton pump inhibitor therapy and hip fracture risk. _h[electronic resource] |
| 260 |
_bJAMA _cApr 2007 |
||
| 300 |
_a1429; author reply 1429-30 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xadverse effects |
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHip Fractures _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProton Pump Inhibitors |
| 650 | 0 | 4 |
_aVitamin D _xmetabolism |
| 650 | 0 | 4 | _aVitamin D Deficiency |
| 700 | 1 | _aAdams, John S | |
| 773 | 0 |
_tJAMA _gvol. 297 _gno. 13 _gp. 1429; author reply 1429-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.297.13.1429-a _zAvailable from publisher's website |
| 999 |
_c16958169 _d16958169 |
||